Glaukos (NYSE:GKOS) reported quarterly earnings results on February 17, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per share of $-0.28,…
Glaukos (NYSE:GKOS) reported quarterly earnings results on February 17, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.28, missing the consensus estimate of $-0.21 by $0.07 per share. Revenue came in at $143.1M, beating the estimate of $137.9M.
Glaukos's stock moved following the earnings release. The stock currently trades at $114.01 with a market capitalization of $6.3B.
Current market data
NYSE · GKOS
$184.89
Unchanged: $0.00 · 0.00%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
